![]() |
市场调查报告书
商品编码
1675078
微孔盘市场 - 成长、未来展望、竞争分析,2025 年至 2033 年Microplates Market - Growth, Future Prospects and Competitive Analysis, 2025 - 2033 |
微孔盘市场规模预计将从 2024 年的 9.9351 亿美元成长到 2033 年的 14.88 亿美元,预测期间(2025-2033 年)的复合年增长率为 4.2%。在过去的几十年里,微孔盘技术在生物技术研究中得到了越来越广泛的应用。研究人员认为该仪器在维持高效、准确的资料结果以及整体研究表现方面发挥着至关重要的作用。多年来,分析测试和测定的性质发生了显着变化,当前的市场趋势是尽量减少药物筛检的数量。微孔盘设计的发展直接源自于这个因素。为了满足研究人员不断变化的需求,需要大量具有不同类型、颜色、孔设计和材质等特征的微孔盘。许多製造商进行的计划的目标之一是减少研究所需的试剂和化学品的数量,同时保持研究过程和结果的品质水平不变。属于微孔盘和微孔盘设备类别的设备和微孔板设备是细胞培养过程以及其他类型研究的重要组成部分。最初,这些设备仅用于实验室等研究环境。然而,如今它在疾病诊断中的应用正在增加,并被诊断实验室和医院广泛使用。因此,它们现在不仅用于了解各种研究中的细胞反应,而且还用于药物开发过程。因此,微孔盘已成为各种测试方法和生产过程中必不可少的组成部分。由于微孔板能够同时分析许多不同的样品,因此研究中对微孔盘的需求正在稳定成长。
ELISA 检测需求不断成长
酵素连结酵素结合免疫吸附检测法(ELISA) 是一种识别荷尔蒙、抗体、胜肽和蛋白质的免疫检测方法。 ELISA检验在生物技术医学中用作诊断工具,透过检测颜色变化来识别目标物质并估计其在测试样本中的含量。这可以透过将样品的颜色与标准进行比较来完成。使用 ELISA 的典型诊断应用包括检测人类免疫力缺乏病毒 (HIV) 感染、怀孕测试以及检测细胞激素、可溶性蛋白质和其他生物标记。免疫测量利用多种抗原-抗体组合,其中一种是酵素标记的(抗原或抗体),然后测量酵素的活性。
高通量筛检中与目标验证和流程自动化相关的高维修成本
目标验证和流程自动化是製药公司在开发过程的高通量筛检阶段遇到的最常见问题的两个问题。在初步筛检期间,研究人员必须克服的最大障碍是确定他们是否使用了正确的药物。如果研究结束时目标识别被证明是不准确的,那么通常会导致因微孔盘、化学物质和人工时间的损失而造成昂贵的浪费。在处理微孔盘的过程中,人为失误(例如有用生物试剂的微小滴度损失、溢出和杂质)可能会导致错误的结果,并经常导致在二次筛检阶段与微量测定相关的设计通讯协定的验证问题。人为错误导致有价值的生物试剂微量滴定液的流失或溢出,增加了新药的高通量筛检。为了减少人为错误而推动微孔盘处理自动化,导致在设计工具和软体以确保平稳操作和预期结果方面损失了大量资金。这是微孔盘处理自动化以减少人为错误的直接结果。
技术相容性和标准化
微孔盘市场的技术相容性和标准化程度相当高。微孔盘是高通量检测和筛检的核心,在研究和诊断实验室中已变得至关重要。确保与微孔盘读数仪、清洗和自动化液体处理系统等各种实验室设备无缝整合至关重要。不同製造商提供的各种设备都有各自的规格,这进一步加剧了这项挑战。微孔盘尺寸、孔深和几何形状的不一致和缺乏标准化会导致严重的操作障碍。如果所使用的微孔盘不能普遍适用于现有的仪器设置,实验室可能会难以实现高效可靠的处理。
新兴国家加大对生物製药产业的投资
微孔盘製造商通常将新兴国家视为其产品的有利可图的市场。这些国家拥有相当一部分目标人口。有几个原因可能会吸引那些面临专利到期、现有市场停滞不前和监管障碍不断增加的大型生物製药公司,但最重要的是提高寿命和提高盈利。这些市场对于生产微孔盘的顶级医疗设备公司的持续扩张至关重要并发挥关键作用。新兴国家占世界人口的很大一部分,其中很大一部分正在积极努力改善医疗体系并取得更好的治疗效果。
按类型细分市场
就微孔盘类型而言,384 孔微孔盘是 2024 年最大的市场,贡献了超过 40.1% 的收益占有率。 384孔微孔盘的最大特点是可以进行小规模的基因转殖实验。这有助于最大限度地减少整个实验过程中支付的成本,同时与其他微孔盘相比,在永生化细胞或原代细胞的转染过程中提供高通量。
按应用细分的市场
疾病标靶发现、药物评估和基因表征等调查方法广泛应用细胞培养作为基本和标准的方法。儘管该过程性质复杂,但与体内研究方法相比,它更容易获得、成本更低、相对省时省力,并且涉及的伦理考虑更少。细胞培养可以藉助巨型生物反应器大规模进行,也可以藉助多壁板小规模进行。微孔盘在细胞培养模型中的使用越来越受欢迎,因为这些模型可以分析许多动态变量,从而改善实验结果,同时减少实验运行所需的时间和成本。
区域市场区隔
北美目前占据 2024 年全球微孔盘市场的最大收益占有率,贡献率约为 30.1%。北美慢性病和急性病患病率的上升以及可及时诊断和治疗的医疗设施的增加是推动该地区市场收益成长的主要驱动因素。此外,预计该地区在整个预测期内仍将保持主导地位。推动该地区市场扩张的另一个因素是生物实验室自动化程度的日益提高。预计预测期内亚太地区的市场将显着成长。这是医疗保健基础设施快速成长以及生物技术和製药研发投资增加的结果。生物研究方法外包的扩大也是一个主要驱动因素。
併购仍是领导企业部署的最重要市场策略之一
由于全球微孔盘市场知名参与者的存在,市场竞争非常激烈。报告中介绍的主要企业简介包括康宁公司 (Corning Incorporated)、赛默飞世尔科技公司 (Thermo Fisher Scientific, Inc)、珀金埃尔默公司 (PerkinElmer, Inc)、Eppendorf AG、Porvair Sciences Limited、Berthold Technologies GmbH &Co.KG、Grel. Laborgerate GmbH &Co.KG。儘管新产品开发在过去五年中仍然是一项关键策略,但趋势已经发生了显着变化。层级公司注重综合策略,包括併购,注重整体发展,而非以产品为导向的策略。例如,只有赛默飞世尔科技在 2020 年至 2021 年期间进行了四次以上的相关收购。 2021 年 9 月,Avantor, Inc. 宣布已签署最终协议,收购 Antylia Scientific 的生物製程业务和相关资产(统称为「Masterflex」)。 Antylia Scientific 是投资公司 GTCR 和 Golden Gate Capital 的投资组合公司。 2021年6月,Avantor也完成了对Ritter GmbH及其附属公司的收购。此次收购旨在加强 Avantor 在分子诊断领域的地位。 COVID-19 对併购市场产生了重大影响,但层级公司正专注于此策略。
The microplates market is set to reach US$ 1488 million by 2033 from US$ 993.51 million in 2024 at a compound annual growth rate (CAGR) of 4.2% during the forecast period from 2025 to 2033. Microplate technologies has been increasingly applied across variety of applications within the field of biotechnology research over the past couple of decades. Researchers are of the opinion that the equipment plays an essential part in the upkeep of productive and accurate data outcomes, as well as in the overall performance of the study. The nature of analytical tests and assays has changed significantly over the course of the years, and a trend toward volume minimization for the purpose of performing drug screening can currently be observed in the market. The design of microplates is evolving as a direct result of this factor. To meet the ever-changing needs of researchers, a significant quantity of microplates, each with its own kind, color, well design, and material, among other characteristics, is necessary. The goal of one of the many projects being pursued by manufacturers is to cut down on the quantity of reagents and chemicals needed for research while maintaining the same level of quality in both the process and the results. Devices belonging to the microplate and microplate instrumentation categories are an essential part of the cell culture process as well as other types of research. In the beginning, these devices were exclusively utilized in research settings, such as laboratories. However, currently there has been increased use in the field of disease diagnosis, which led to their presence in diagnostic laboratories as well as hospitals. As a result, microplates are used in the process of drug discovery and development, in addition to comprehending the cellular reactions in any type of research. As a result, microplates are necessary components in a variety of testing methods and production processes. The need for microplates in research settings is steadily increasing as a direct result of their capacity to perform simultaneous analysis on a number of different samples.
Increasing Demand for ELISA Testing
The Enzyme-Linked Immunosorbent Assay, more often known as ELISA, is a type of immunoassay that may recognize hormones, antibodies, peptides, and proteins. The ELISA assay has applications in biotechnology medicine as a diagnostic tool that detects a color change to identify a target substance and estimates its quantity in the test sample. This can be done by comparing the color of the sample to a standard. Infection with the Human Immunodeficiency Virus (HIV), tests to determine whether or not a woman is pregnant, and the detection of cytokines, soluble proteins, and other biomarkers are typical diagnostic applications of ELISA. The immunoassay makes use of a wide variety of antigen-antibody combinations, one of which is enzyme-labeled (either the antigen or the antibody), and measures the activity of the enzyme.
High Maintenance Cost Associated with Target Validation and Process Automation Pertaining to High Throughput Screening
Target validation and process automation are the two issues that pharmaceutical companies run into most frequently during the high throughput screening stages of the development process. During the main screening, the greatest obstacle that researchers must overcome is determining whether or not they are working with the appropriate drug. If the target identification is revealed to be incorrect at the conclusion of the test, this frequently leads to a wasteful endeavor that costs money due to the loss of microplates, chemicals, and working hours. Accidents caused by humans, such as the loss of micro titers of useful biological reagents, spilling, and the addition of impurities while handling microplates, have led to erroneous results, which have frequently led to validation issues of designed protocols pertaining to micro assays during the secondary screening stage. Human errors, such as the loss of micro titers of useful biological reagents, spilling, and the addition of high throughput screening of novel drugs, the automation of microplate handling to reduce human error is resulting in the loss of huge funds to design tools and software to ensure smooth operations and desired results. This is a direct result of the automation of microplate handling to reduce human error.
Technological Compatibility and Standardization
Technological Compatibility and Standardization in the microplate market is a substantial one. Microplates are central to high-throughput assays and screenings, making them integral in research and diagnostic laboratories. Ensuring they seamlessly integrate with various laboratory instruments, such as microplate readers, washers, and automated liquid handling systems, is crucial. The diversity of equipment from different manufacturers each with their unique specifications, exacerbates the challenge. Inconsistencies or lack of standardization in microplate dimensions, well depth, and shape can lead to significant operational hurdles. Labs may encounter difficulties in achieving efficient and reliable processing if the microplates used are not universally compatible with their existing equipment setup.
Increasing Investment in The Biopharmaceutical Industry in Emerging Economies
Manufacturers of microplates often view emerging economies as lucrative destinations to sell their products. These nations are home to significant portions of the target population. The key biopharmaceutical players who are experiencing patent expirations, stagnation of established markets, and rising regulatory hurdles can be attracted to your company for a number of reasons, but the most important ones are improving lifespan and expanding profitability. These markets are extremely important to the continued expansion of top medical device firms that manufacture microplates, and they play an important part in that expansion. Developing countries are home to a sizeable portion of the world's population, and a large fraction of that population is actively working to improve their healthcare systems and achieve better treatment outcomes.
Market Segmentation By Type
With respect to the type of microplates, the 384-well microplates were the largest market in 2024 contributing to over 40.1% of the revenue share. Their capacity to carry out miniature gene transfer experiments is the defining characteristic that contributes most significantly to their preeminence. This assists in minimizing the cost that is paid throughout the procedures of the experiment, and at the same time, it gives a high throughput during the transfection of immortalized and primary cells in contrast to other microplates.
Market Segmentation By Application
Research techniques such as the discovery of disease targets, drug assessment, and gene characterization extensively apply cell culture as a fundamental and standard methodology. The nature of this process is complex; nonetheless, it is significantly easier to access, less expensive, and comparatively time and labor efficient than in vivo research approaches, and it also has fewer ethical considerations. Cell culture can be carried out at a large scale with the assistance of huge bioreactors, or it can be carried out at a small size with the assistance of multiwall plates. The use of microplates in cell culture models is gaining popularity because these models enable the analysis of a multitude of dynamic variables, which in turn enables increased experiment output while simultaneously lowering the amount of time and money required for the experiment.
Market Segmentation By Geography
North America currently held the largest revenue share in the global microplates market in 2024 by contributing to about 30.1%. The rising prevalence of chronic and acute disease conditions in North America, as well as the widespread availability of healthcare facilities for prompt diagnosis and treatment are the key drivers boosting the market revenues in this region. This region is also expected to maintain its leading position throughout the duration of the forecast period. Another factor contributing to the expansion of the market in this region is the increasing trend of automation in biolaboratories. It is anticipated that the Asia Pacific region would experience significant market expansion over the course of the projected period. This occurs as a result of the rapid growth of the infrastructure of healthcare and the increased investments in research and development of biotechnology and medicines. The growing outsourcing of biotechnology contract research processes is also among the key drivers.
M&A Remains One of the Most Significant Market Strategies Deployed by Top Companies
The global microplates market is characterized by some notable players and hence, the market is quite fierce in terms of competition. Key players profiled in the report include Corning Incorporated, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Eppendorf AG, Porvair Sciences Limited, Berthold Technologies GmbH & Co. KG, Greiner Bio One International GmbH, Avantor, Inc., Becton, Dickison and Company, QIAGEN N.V., SPL Life Sciences, Hirschmann Laborgerate GmbH & Co. KG, among others. Though new product development has remained the key strategy in the previous 5 years, the trend has changed significantly. Tier 1 companies are focusing on umbrella strategies which include mergers and acquisitions focused on holistic development rather than product-oriented strategies. For example, only Thermo Fischer has performed over 4 relevant acquisitions during the period of 2020 to 2021. In Sep 2021 Avantor, Inc announced that it has entered into a definitive agreement to acquire the Masterflex bioprocessing business and related assets (collectively "Masterflex") of Antylia Scientific, a privately held, portfolio company of investment firms GTCR and Golden Gate Capital. In June 2021, Avantor also completed the acquisition of Ritter GmbH and its AffiliatesThe acquisition aims at enhancing the company's position in the field of molecular diagnostics as a whole. Though COVID-19 has impacted the market largely with respect to mergers and acquisitions, Tier 1 companies have focused on this strategy.
Historical & Forecast Period
This study report represents an analysis of each segment from 2023 to 2033 considering 2024 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2025 to 2033.
The current report comprises quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends & technological analysis, case studies, strategic conclusions and recommendations and other key market insights.
Research Methodology
The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. The key data points that enable the estimation of Microplates market are as follows:
Research and development budgets of manufacturers and government spending
Revenues of key companies in the market segment
Number of end users & consumption volume, price, and value.
Geographical revenues generated by countries considered in the report
Micro and macro environment factors that are currently influencing the Microplates market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top-down and bottom-up approach for validation of market estimation assures logical, methodical, and mathematical consistency of the quantitative data.